Active Not RecruitingNCT07458022

MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER

Medication studyAges 18+PakistanDepression

The study in practice

Understand this study

Listed age limits: from 18 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: December 1, 2025

Recruitment status: Active Not Recruiting
Enrollment listed in the registry: 50
Sponsor: University of Child Health Sciences and Children's Hospital, Lahore
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: Pakistan
Age range: Over 18 Years
Official registry ID: NCT07458022
Official title: Show the full official title
MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Not recruiting

Multan

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is University of Child Health Sciences and Children's Hospital, Lahore, a university.

Does this study involve medication?

Yes. The study involves medication, including Use of magnesium with SSRI and SSRI.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.